Evidence map›Paper›PMID 41471055›Full record

ArticlePharmaceutics2025

Generation of a Bioengineered Substitute of the Human Sclero-Corneal Limbus Using a Novel Decellularization Method.

Paula Ávila-Fernández, David Sánchez-Porras, Miguel Etayo-Escanilla, Carmen González-Gallardo, Miguel Alaminos, Jesús Chato-Astrain, Fernando Campos, Óscar Darío García-García

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paula Ávila-FernándezTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, 18016 Granada, Spain.ORCID 0000-0002-0328-4112
David Sánchez-PorrasTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, 18016 Granada, Spain.ORCID 0000-0002-4755-7741
Miguel Etayo-EscanillaTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, 18016 Granada, Spain.ORCID 0009-0000-9205-7933
Carmen González-GallardoTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, 18016 Granada, Spain.
Miguel AlaminosTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, 18016 Granada, Spain.ORCID 0000-0003-4876-2672
Jesús Chato-AstrainTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, 18016 Granada, Spain.ORCID 0000-0002-2378-2696
Fernando CamposTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, 18016 Granada, Spain.ORCID 0000-0003-0034-9264
Óscar Darío García-GarcíaTissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, 18016 Granada, Spain.ORCID 0000-0002-4710-0733

Funding

Consejería de Salud y Consumo, Junta de Andalucía, Spain CSyF PI-0086-2020Instituto de Salud Carlos III (ISCIII), Ministry of Science, Innovation and Universities FIS PI20/00317Instituto de Salud Carlos III (ISCIII), Ministry of Science, Innovation and Universities FIS PI23/00335Instituto de Salud Carlos III (ISCIII), Ministry of Science, Innovation and Universities ICI21/00010
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

advanced therapiesbiofabricationdecellularizationsclero-corneal limbustissue engineering

Identifiers

PMID41471055
PMCPMC12736053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.